Longevity record for a wild European rabbit (Oryctolagus cuniculus) from South Australia

2009 ◽  
Vol 31 (1) ◽  
pp. 65 ◽  
Author(s):  
David E. Peacock ◽  
Ron G. Sinclair
Keyword(s):  
Epidemiological Study ◽  
Oryctolagus Cuniculus ◽  
South Australia ◽  
European Rabbit ◽  
Birth Date ◽  
Review Of The Literature ◽  
Rabbit Haemorrhagic Disease ◽  
In The Wild ◽  
European Rabbits ◽  
Haemorrhagic Disease

A population of European rabbits (Oryctolagus cuniculus) has been monitored since November 1996 through mark–recapture as part of a longitudinal epidemiological study into two Australian rabbit biocontrol agents, rabbit haemorrhagic disease (RHD) and myxomatosis. A female rabbit, first captured as a subadult in late November 1999, was recaptured 18 times before its final capture at the end of February 2007. The longevity of this rabbit, being from its calculated birth date to the date it was last captured, was 7.6 years. A review of the literature indicates this to be the longest lifespan recorded for a European rabbit in the wild.

Substantial numerical decline in South Australian rabbit populations following the detection of rabbit haemorrhagic disease virus 2

2018 ◽  
Vol 182 (20) ◽  
pp. 574-574 ◽  
Author(s):  
Greg Mutze ◽  
Nicki De Preu ◽  
Trish Mooney ◽  
Dylan Koerner ◽  
Darren McKenzie ◽  
...  
Keyword(s):  
Disease Virus ◽  
South Australia ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Environmental Benefit ◽  
Rabbit Haemorrhagic Disease ◽  
European Rabbits ◽  
Haemorrhagic Disease ◽  
The Impact ◽  
Term Monitoring

Lagovirus europaeus GI.2, also commonly known as rabbit haemorrhagic disease virus 2, was first detected at two long-term monitoring sites for European rabbits, Oryctolagus cuniculus, in South Australia, in mid-2016. Numbers of rabbits in the following 12–18 months were reduced to approximately 20 per cent of average numbers in the preceding 10 years. The impact recorded at the two South Australian sites, if widespread in Australia and persistent for several years, is likely to be of enormous economic and environmental benefit.

Temporal dynamics of rabbit haemorrhagic disease virus infection in a low-density population of wild rabbits (Oryctolagus cuniculus) in New Zealand

2006 ◽  
Vol 33 (4) ◽  
pp. 293 ◽  
Author(s):  
J. Henning ◽  
D. U. Pfeiffer ◽  
P. R. Davies ◽  
J. Meers ◽  
R. S. Morris
Keyword(s):  
New Zealand ◽  
Disease Virus ◽  
Oryctolagus Cuniculus ◽  
Temporal Dynamics ◽  
Population Decline ◽  
Adult Survivors ◽  
European Rabbit ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Rabbit Haemorrhagic Disease ◽  
Haemorrhagic Disease

A longitudinal capture–mark–recapture study was conducted to determine the temporal dynamics of rabbit haemorrhagic disease (RHD) in a European rabbit (Oryctolagus cuniculus) population of low to moderate density on sand-hill country in the lower North Island of New Zealand. A combination of sampling (trapping and radio-tracking) and diagnostic (cELISA, PCR and isotype ELISA) methods was employed to obtain data weekly from May 1998 until June 2001. Although rabbit haemorrhagic disease virus (RHDV) infection was detected in the study population in all 3 years, disease epidemics were evident only in the late summer or autumn months in 1999 and 2001. Overall, 20% of 385 samples obtained from adult animals older than 11 weeks were seropositive. An RHD outbreak in 1999 contributed to an estimated population decline of 26%. A second RHD epidemic in February 2001 was associated with a population decline of 52% over the subsequent month. Following the outbreaks, the seroprevalence in adult survivors was between 40% and 50%. During 2000, no deaths from RHDV were confirmed and mortalities were predominantly attributed to predation. Influx of seronegative immigrants was greatest in the 1999 and 2001 breeding seasons, and preceded the RHD epidemics in those years. Our data suggest that RHD epidemics require the population immunity level to fall below a threshold where propagation of infection can be maintained through the population.

Myxoma virus and rabbit haemorrhagic disease virus 2 coinfection in a European wild rabbit (Oryctolagus cuniculus algirus), Portugal

2020 ◽  
Vol 8 (1) ◽  
pp. e001002 ◽  
Author(s):  
Carina Luisa Carvalho ◽  
Fábio Alexandre Abade dos Santos ◽  
Teresa Fagulha ◽  
Paulo Carvalho ◽  
Paula Mendonça ◽  
...  
Keyword(s):  
Disease Virus ◽  
Oryctolagus Cuniculus ◽  
Rare Event ◽  
Myxoma Virus ◽  
European Rabbit ◽  
Wild Rabbit ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Sample Collection ◽  
Rabbit Haemorrhagic Disease ◽  
Haemorrhagic Disease

Myxoma virus (MYXV) and rabbit haemorrhagic disease virus 2 (RHDV2) are two major pathogens that affect the European rabbit (Oryctolagus cuniculus). Between August 2017 and August 2019, 1166 wild rabbits (971 legally hunted and 195 found dead) were tested by PCR-based methods for MYXV and RHDV2 within the scope of an ongoing surveillance programme on wild leporids in Portugal. Despite never having been reported before and being considered a rare event, coinfection by RHDV2 and MYXV was detected in one juvenile wild rabbit found dead in the Évora district located in Alentejo. The relative frequency of coinfection in the group of diseased rabbits (found dead in the field) was 0.52 per cent (1/195). The positivity percentage of each single virus was much higher, namely, 14.36 per cent (28/195) for MYXV and 55.38 per cent (108/195) for RHDV2, within the 2 years of sample collection considered.

Evolution of rabbit haemorrhagic disease virus (RHDV) in the European rabbit (Oryctolagus cuniculus) from the Iberian Peninsula

2009 ◽  
Vol 135 (3-4) ◽  
pp. 368-373 ◽  
Author(s):  
A. Muller ◽  
J. Freitas ◽  
E. Silva ◽  
G. Le Gall-Reculé ◽  
F. Zwingelstein ◽  
...  
Keyword(s):  
Iberian Peninsula ◽  
Disease Virus ◽  
Oryctolagus Cuniculus ◽  
European Rabbit ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Rabbit Haemorrhagic Disease ◽  
Haemorrhagic Disease

Population and demographic patterns of rabbits (Oryctolagus cuniculus) at Roxby Downs in arid South Australia and the influence of rabbit haemorrhagic disease

1998 ◽  
Vol 25 (6) ◽  
pp. 655 ◽  
Author(s):  
Zoë Bowen ◽  
John Read
Keyword(s):  
Oryctolagus Cuniculus ◽  
South Australia ◽  
Late Summer ◽  
Early Summer ◽  
Myxoma Virus ◽  
Late Winter ◽  
Virus Vectors ◽  
Rabbit Haemorrhagic Disease ◽  
Demographic Patterns ◽  
Haemorrhagic Disease

Rabbit populations and demography were surveyed at Roxby Downs in arid South Australia from 1989 to 1997. Rabbit numbers typically peaked in late summer following breeding from late winter to early summer. After initial declines attributable to burrow flooding and increased populations of virus vectors, rabbit numbers increased by approximately 400% after significant rains. Introductions of Spanish rabbit flea, a vector of Myxoma virus, did not influence rabbit numbers but rabbit haemorrhagic disease (RHD) had a dramatic and sustained influence on rabbit numbers. The optimum times for release of RHD are discussed.

scholarly journals Molecular epidemiology of Rabbit haemorrhagic disease virus

2002 ◽  
Vol 83 (10) ◽  
pp. 2461-2467 ◽  
Author(s):  
S. R. Moss ◽  
S. L. Turner ◽  
R. C. Trout ◽  
P. J. White ◽  
P. J. Hudson ◽  
...  
Keyword(s):  
Disease Virus ◽  
Nucleotide Sequencing ◽  
Molecular Evidence ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Rabbit Haemorrhagic Disease ◽  
Molecular Phylogenetic ◽  
Virulent Virus ◽  
Rabbit Bone ◽  
European Rabbits ◽  
Haemorrhagic Disease

Millions of domestic and wild European rabbits (Oryctolagus cuniculus) have died in Europe, Asia, Australia and New Zealand during the past 17 years following infection by Rabbit haemorrhagic disease virus (RHDV). This highly contagious and deadly disease was first identified in China in 1984. Epidemics of RHDV then radiated across Europe until the virus apparently appeared in Britain in 1992. However, this concept of radiation of a new and virulent virus from China is not entirely consistent with serological and molecular evidence. This study shows, using RT–PCR and nucleotide sequencing of RNA obtained from the serum of healthy rabbits stored at 4 °C for nearly 50 years, that, contrary to previous opinions, RHDV circulated as an apparently avirulent virus throughout Britain more than 50 years ago and more than 30 years before the disease itself was identified. Based on molecular phylogenetic analysis of British and European RHDV sequences, it is concluded that RHDV has almost certainly circulated harmlessly in Britain and Europe for centuries rather than decades. Moreover, analysis of partial capsid sequences did not reveal significant differences between RHDV isolates that came from either healthy rabbits or animals that had died with typical haemorrhagic disease. The high stability of RHDV RNA is also demonstrated by showing that it can be amplified and sequenced from rabbit bone marrow samples collected at least 7 weeks after the animal has died.

scholarly journals Novel Trivalent Vectored Vaccine for Control of Myxomatosis and Disease Caused by Classical and a New Genotype of Rabbit Haemorrhagic Disease Virus

Vaccines ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. 441 ◽  
Author(s):  
Sylvia Reemers ◽  
Leon Peeters ◽  
Joyce van Schijndel ◽  
Beth Bruton ◽  
David Sutton ◽  
...  
Keyword(s):  
Disease Virus ◽  
Myxoma Virus ◽  
European Rabbit ◽  
Viral Diseases ◽  
Serological Response ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Rabbit Haemorrhagic Disease ◽  
New Genotype ◽  
Vectored Vaccine ◽  
Haemorrhagic Disease

Myxoma virus (MV) and rabbit haemorrhagic disease virus (RHDV) are the major causes of lethal viral diseases in the European rabbit. In 2010, a new RHDV genotype (RHDV2) emerged in the field that had limited cross-protection with the classical RHDV (RHDV1). For optimal protection of rabbits and preventing spread of disease, a vaccine providing protection against all three key viruses would be ideal. Therefore, a novel trivalent myxoma vectored RHDV vaccine (Nobivac Myxo-RHD PLUS) was developed similar to the existing bivalent myxoma vectored RHDV vaccine Nobivac Myxo-RHD. The new vaccine contains the Myxo-RHDV1 strain already included in Nobivac Myxo-RHD and a similarly produced Myxo-RHDV2 strain. This paper describes several key safety and efficacy studies conducted for European licensing purposes. Nobivac Myxo-RHD PLUS showed to be safe for use in rabbits from five weeks of age onwards, including pregnant rabbits, and did not spread from vaccinated rabbits to in-contact controls. Furthermore, protection to RHDV1 and RHDV2 was demonstrated by challenge, while the serological response to MV was similar to that after vaccination with Nobivac Myxo-RHD. Therefore, routine vaccination with Nobivac Myxo-RHD PLUS can prevent the kept rabbit population from these major viral diseases.

scholarly journals Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculus

1997 ◽  
Vol 31 (1) ◽  
pp. 33-44 ◽  
Author(s):  
David Chasey
Keyword(s):  
Incubation Period ◽  
Oryctolagus Cuniculus ◽  
Accidental Release ◽  
Domestic Rabbit ◽  
Rabbit Haemorrhagic Disease ◽  
Subsequent Exposure ◽  
Haemorrhagic Disease ◽  
Very High ◽  
Infectious Condition ◽  
Important Disease

A new, widespread and important disease of rabbits, rabbit haemorrhagic disease (RHD), is concisely reviewed and discussed. RHD is an acute, infectious condition of adult rabbits and morbidity and mortality, after a relatively short incubation period, can be very high. The disease appears typically as a necrotizing hepatitis with associated haemorrhaging, and death occurs as a result of generalized organ dysfunction. RHD is caused by a calicivirus, antigenically related to a similar virus found in brown hares but distinct from other known caliciviruses, and is spread to susceptible rabbits by a number of routes and vectors. The disease is easily identified and can be effectively controlled in commercial and domestic rabbit populations by slaughter and vaccination regimes. The occurrence of pre-existing cross-reacting antibody in a proportion of rabbits unchallenged by the disease implies the presence of non-pathogenic strains of the virus. This antibody protects against disease on subsequent exposure to RHD. Uniquely, pre-existing antibody does not occur in rabbits in Australia where, after accidental release, the virus is currently spreading rapidly.

Potential use of myxoma virus and rabbit haemorrhagic disease virus to control feral rabbits in the Kerguelen Archipelago

2004 ◽  
Vol 31 (4) ◽  
pp. 415 ◽  
Author(s):  
B. D. Cooke ◽  
J.-L. Chapuis ◽  
V. Magnet ◽  
A. Lucas ◽  
J. Kovaliski
Keyword(s):  
Disease Virus ◽  
Disease Transmission ◽  
Biological Control Agent ◽  
Myxoma Virus ◽  
European Rabbit ◽  
Rabbit Haemorrhagic Disease Virus ◽  
Rabbit Haemorrhagic Disease ◽  
Haemorrhagic Disease ◽  
Low Prevalence ◽  
Kerguelen Archipelago

Rabbits have caused enormous damage to the vegetation on seven islands in the sub-Antarctic Kerguelen archipelago, including the main island, Grande Terre. Rabbit sera collected during 2001–02 were tested for antibodies against myxoma virus and rabbit haemorrhagic disease virus with a view to considering the wider use of these viruses to control rabbits. The results confirmed work done 15–20 years earlier that suggested that myxoma virus has not spread across all parts of Grande Terre and occurs at low prevalence among rabbits. By contrast, on Ile du Cimetière, where European rabbit fleas were introduced in 1987–88, the prevalence of myxoma antibodies is high and the rabbit population is relatively low, supporting the idea that the fleas are effective vectors of myxoma virus. Consequently, there should be benefits in releasing fleas on Grand Terre to enhance disease transmission. Reactivity of some rabbit sera in RHD-specific ELISAs suggested that a virus similar to RHDV may be present at low prevalence on Grande Terre but most rabbits are likely to be susceptible and this virus could be considered for use as a future biological control agent.

Sign in / Sign up

Export Citation Format

Share Document